Literature DB >> 2765781

Ambulatory monitoring of bladder pressures in patients with low compliance as a result of neurogenic bladder dysfunction.

R J Webb1, R A Styles, C J Griffiths, P D Ramsden, D E Neal.   

Abstract

A group of 28 patients with neurogenic bladder dysfunction and low bladder compliance was studied using medium fill cystometry (CMG) and ambulatory monitoring (AM) during natural bladder filling. The aims of the study were to compare the 2 techniques and to determine if ambulatory monitoring might be useful in predicting upper tract dilatation. AM demonstrated significantly lower end filling pressures compared with CMG. Phasic detrusor contractions were found more commonly during AM and the frequency of phasic detrusor contractions during AM was associated significantly with poor compliance identified during CMG. Patients with upper tract dilatation had significantly greater residual urine volumes, higher pressure rises during CMG and higher frequencies of phasic detrusor contractions compared with those patients with normal upper tracts. The high pressures seen at the end of a medium fill CMG were not found during AM and therefore are unlikely to be the underlying explanation of upper tract dilatation in such patients.

Entities:  

Mesh:

Year:  1989        PMID: 2765781     DOI: 10.1111/j.1464-410x.1989.tb05976.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  Review of augmentation 'clam' cystoplasy in a district general hospital setting.

Authors:  K D Ivil; G Suresh
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Irreversible renal failure in men with outflow obstruction: is it a preventable disease?

Authors:  D E Neal
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 3.  Ambulatory monitoring.

Authors:  K Brown; P Hilton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

Review 4.  Current concepts and controversies in urodynamics.

Authors:  C E Kelly; R J Krane
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.